Practice Management

Mental health disorders like PTSD and depression might not be as much of a barrier to cardiac rehabilitation as was previously thought, according to a study of more than 85,000 U.S. veterans published in the Journal of the American Heart Association.

More than two-thirds of CV randomized clinical trial reports positively spin some aspect of the article to reflect favorable results that aren’t necessarily there, according to a study published in the May edition of JAMA Network Open.

Researchers say such misnomers could have major policy implications, especially in an increasingly value-based landscape.

A trio of studies presented at the Heart Rhythm Society’s 40th annual scientific sessions earlier this month highlight significant disparities in patient access to implantable cardiac devices—particularly in women and black patients.

An artificial intelligence “super brain” could help eliminate unnecessary diagnostic testing in patients who present with stable chest pain, according to a recent study, potentially saving physicians and patients significant time and money.

The Heart Rhythm Society issued a first-ever consensus statement on the evaluation, risk stratification and management of arrhythmogenic cardiomyopathy at its annual conference in San Francisco this spring.

The bioresorbable vascular scaffold, once an exciting prospect for cardiologists, saw a unique rise and fall in popularity within a year of its introduction to the CV market.

Nearly one in six young women who suffer a heart attack can’t be classified under the Fourth Universal Definition of MI, according to a study out of Yale University—but the majority can be accurately classified using a sex-specific taxonomy known as VIRGO.

Cardio-oncology has emerged as an area of rapid growth in the medical community in recent years, owing in large part to an increasing population of cancer survivors.

Stress disorders like PTSD and adjustment disorder were linked to adverse cardiovascular outcomes in a recent BMJ study, Reuters reports, with the greatest CV risk posed in the months directly after a patient is diagnosed with such a condition.

Supplementing standard physicals with Abbott’s high-sensitivity troponin-I blood test could boost the accuracy of CVD prediction in middle-aged patients, according to research published in Circulation April 29.

The FDA has cleared Current Health’s wireless wearable remote patient monitoring (RPM) platform for chronically ill individuals, allowing care teams to track their patients’ health in real-time and act proactively when something looks off.